Francesco Feroci

Hospital of Prato, Azienda Usl Toscana Centro

Papers

2

Total Citations

88

H-Index

2

About

Francesco Feroci is a leading figure in minimally invasive surgical oncology, with a primary focus on advancing techniques for colorectal and adrenal cancers. His most cited work, a 2016 study comparing laparoscopic and robotic total mesorectal excision (TME) for mid and low rectal cancer, has garnered 77 citations and remains a cornerstone in the debate over optimal minimally invasive approaches. This retrospective analysis of 111 patients provided critical short- and long-term outcome data, helping to refine surgical decision-making. More recently, Feroci has contributed to the nuanced field of adrenal surgery, authoring a 2023 collective overview on the key surgical factors influencing outcomes in minimally invasive versus open adrenalectomy for adrenocortical carcinoma. His research consistently emphasizes the balance between oncologic radicality and the benefits of reduced surgical trauma. Feroci’s work is distinguished by its practical, evidence-based focus, directly informing the choices surgeons make in the operating room. With a career dedicated to evaluating and advancing laparoscopic and robotic techniques, he has established himself as a key voice in the evolution of modern surgical oncology, particularly in optimizing patient outcomes through rigorous comparative studies.

Research Focus

Key Achievements

2
H-Index
2
Papers
88
Total Citations
44
Avg Citations/Paper
🏆 Most Cited Paper
Total mesorectal excision for mid and low rectal cancer: Laparoscopic<i>vs</i>robotic surgery
77 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Hospital of Prato, Azienda Usl Toscana Centro

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago